We are live on ! Find out more
ORIAU

Orion Biotech Opportunities Corp. Units
ORIAU

Delisted

ORIAU was delisted on the 25th of April, 2023.

Back to rankings

18 hedge funds and large institutions have $56.2M invested in Orion Biotech Opportunities Corp. Units in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less funds holding

Funds holding: 21 → 18 (-3)

24% less capital invested

Capital invested by funds: $73.8M → $56.2M (-$17.6M)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
1
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$5.97K
2
UBS Group
UBS Group
Switzerland
+$1.26K

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$5.96M
2
SCM
Shaolin Capital Management
Florida
-$5.18M
3
KC
Kepos Capital
New York
-$4.96M
4
Millennium Management
Millennium Management
New York
-$2.49M
5
SC
Sculptor Capital
New York
-$1.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP
1
JNE Partners
United Kingdom
$14.8M – – –
LA
2
Linden Advisors
New York
$6.93M – – –
MF
3
Magnetar Financial
Illinois
$5.94M – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
4
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$4.95M – – –
PSAMP
5
P. Schoenfeld Asset Management (PSAM)
New York
$4.93M – – –
Calamos Advisors
6
Calamos Advisors
Illinois
$3.71M – – –
Jane Street
7
Jane Street
New York
$3.68M +$5.97K +600 +0.2%
CF
8
Cantor Fitzgerald
New York
$2.86M +$2.92M +293,200 New
GCL
9
Glazer Capital LLC
New York
$2.05M -$302K -30,390 -13%
FTCM
10
First Trust Capital Management
Illinois
$1.73M – – –
CCM
11
Context Capital Management
California
$1.04M – – –
WC
12
Wealthspring Capital
New York
$1.03M -$69.6K -7,000 -6%
SIA
13
Schechter Investment Advisors
Michigan
$927K +$945K +95,000 New
SMA
14
Sage Mountain Advisors
Georgia
$781K – – –
COPPSERS
15
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$495K – – –
Millennium Management
16
Millennium Management
New York
$355K -$2.49M -250,000 -87%
6CM
17
683 Capital Management
New York
$10K – – –
UBS Group
18
UBS Group
Switzerland
$1K +$1.26K +127 New
PC
19
Periscope Capital
Ontario, Canada
– -$5.96M -600,000 Closed
SCM
20
Shaolin Capital Management
Florida
– -$5.18M -523,570 Closed
KC
21
Kepos Capital
New York
– -$4.96M -500,000 Closed
SC
22
Sculptor Capital
New York
– -$1.24M -125,000 Closed
LOAMU
23
Lombard Odier Asset Management (USA)
New York
– -$495K -50,000 Closed
OAC
24
OMERS Administration Corp
Ontario, Canada
– -$400K -40,000 Closed

ORIAU Hedge Fund Activity: Q4 2021 in Review

18 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q4 2021, worth a combined $56.2M — down 24% from $73.8M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ORIAU and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Jane Street, adding an estimated $5.97K. The largest seller was Periscope Capital, exiting entirely with an estimated $5.96M sold.

  • 18 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q4 2021, down from 21 in Q3 2021.
  • Funds reported $56.2M of Orion Biotech Opportunities Corp. Units stock for Q4 2021, down 24% quarter-over-quarter.
  • 3 funds opened new Orion Biotech Opportunities Corp. Units positions in Q4 2021 and 6 closed out, a net change of -3 holders.
  • The largest Orion Biotech Opportunities Corp. Units buyer in Q4 2021 was Jane Street, an estimated $5.97K added.
  • The largest Orion Biotech Opportunities Corp. Units seller in Q4 2021 was Periscope Capital, an estimated $5.96M sold.

Based on aggregated 13F filings for Q4 2021.